UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

Clinical infectious diseases, 2008-04, Vol.46 (7), p.1015-1023

2008

Volltextzugriff (PDF)

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

Vaccine, 2011-07, Vol.29 (32), p.5195-5202

2011

Volltextzugriff (PDF)

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants

Vaccine, 2011-12, Vol.29 (52), p.9675-9683

2011

Volltextzugriff (PDF)

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18–49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine

Vaccine, 2015-10, Vol.33 (43), p.5854-5860

2015

Volltextzugriff (PDF)

Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

Science (American Association for the Advancement of Science), 2000-10, Vol.290 (5491), p.486-492

2000

Volltextzugriff (PDF)

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

The New England journal of medicine, 1997-09, Vol.337 (11), p.734-739

1997

Volltextzugriff (PDF)

Viral dynamics in human immunodeficiency virus type 1 infection

Nature (London), 1995-01, Vol.373 (6510), p.117-122

1995

Volltextzugriff (PDF)

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Annals of internal medicine, 2000-07, Vol.133 (1), p.35

2000

Volltextzugriff (PDF)

Active Human Immunodeficiency Virus Protease is Required for Viral Infectivity

Proceedings of the National Academy of Sciences - PNAS, 1988-07, Vol.85 (13), p.4686-4690

1988

Volltextzugriff (PDF)

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

JAMA : the journal of the American Medical Association, 1998-07, Vol.280 (1), p.35

1998

Volltextzugriff (PDF)

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

Annual review of medicine, 2004-01, Vol.55 (1), p.355-372

2004

Volltextzugriff (PDF)

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

Journal of Virology, 1992-12, Vol.66 (12), p.7538-7542

1992

Volltextzugriff (PDF)

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

Journal of Virology, 1991-09, Vol.65 (9), p.4887-4892

1991

Volltextzugriff (PDF)

Neutralization of Divergent Human Immunodeficiency Virus Type 1 Variants and Primary Isolates by IAM-41-2F5, an Anti-gp41 Human Monoclonal Antibody

Proceedings of the National Academy of Sciences - PNAS, 1994-04, Vol.91 (8), p.3348-3352

1994

Volltextzugriff (PDF)

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

Journal of Virology, 1992-12, Vol.66 (12), p.7414-7419

1992

Volltextzugriff (PDF)

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor

Proceedings of the National Academy of Sciences - PNAS, 1994-04, Vol.91 (9), p.4096-4100

1994

Volltextzugriff (PDF)

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

Journal of Virology, 1985-09, Vol.55 (3), p.836-839

1985

Volltextzugriff (PDF)

L-735,524 : the design of a potent and orally bioavailable HIV protease inhibitor

Journal of medicinal chemistry, 1994-10, Vol.37 (21), p.3443-3451

1994

Volltextzugriff (PDF)

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

Vaccine, 2004-08, Vol.22 (23), p.2993-3003

2004

Volltextzugriff (PDF)

Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody

Nature (London), 1992-02, Vol.355 (6362), p.728-730

1992

Volltextzugriff (PDF)

Inhibition of human immunodeficiency virus integrase by bis-catechols

Antimicrobial Agents and Chemotherapy, 1995-02, Vol.39 (2), p.320-324

1995

Volltextzugriff (PDF)

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

Journal of Virology, 2003-06, Vol.77 (11), p.6305-6313

2003

Volltextzugriff (PDF)

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

Journal of Virology, 1994-11, Vol.68 (11), p.6994-7000

1994

Volltextzugriff (PDF)

Factors Influencing the Emergence of Resistance to Indinavir: Role of Virologic, Immunologic, and Pharmacologic Variables

The Journal of infectious diseases, 1998-08, Vol.178 (2), p.360-367

1998

Volltextzugriff (PDF)

The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate

Journal of Virology, 1996-10, Vol.70 (10), p.6751-6758

1996

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Englisch
(237)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(147)
Humans
(114)
Biological And Medical Sciences
(111)
Aids/hiv
(77)
Animals
(76)
Virology
(71)
Microbiology
(64)
Fundamental And Applied Biological Sciences. Psychology
(60)
Pharmacology & Pharmacy
(56)
Medical Sciences
(55)
Chemistry
(53)
Human Immunodeficiency Virus 1
(53)
Antiviral Agents
(49)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(47)
Chemistry, Medicinal
(47)
Pharmacology. Drug Treatments
(47)
Hiv-1 - Drug Effects
(40)
Structure-Activity Relationship
(38)
Molecular Sequence Data
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18–49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine

Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Viral dynamics in human immunodeficiency virus type 1 infection

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Active Human Immunodeficiency Virus Protease is Required for Viral Infectivity

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

Neutralization of Divergent Human Immunodeficiency Virus Type 1 Variants and Primary Isolates by IAM-41-2F5, an Anti-gp41 Human Monoclonal Antibody

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

L-735,524 : the design of a potent and orally bioavailable HIV protease inhibitor

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody

Inhibition of human immunodeficiency virus integrase by bis-catechols

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

Factors Influencing the Emergence of Resistance to Indinavir: Role of Virologic, Immunologic, and Pharmacologic Variables

The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate

Suchergebnisse filtern